ArticlePloS one2024
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.
Ana Ruigómez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it